About Inbiome

Founded with a mission to revolutionize the diagnostics industry, inbiome leverages cutting-edge molecular technologies in combination with modern AI to develop diagnostic solutions that are fast, accurate, and accessible. The company’s groundbreaking work is poised to set new standards in the field of infectious disease diagnostics, contributing significantly to patient care and the global fight against antimicrobial resistance.

Inbiome co-operates with US and European industry leaders across the medical, technology and biotechnology industries, as well as prestigious academic institutions, on both clinical and commercial research and product development.